Geographically, North America dominated the vascular stents market, because of the growing number of patients suffering from cardiovascular diseases, high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing aging population, rise in consumer awareness, increasing healthcare expenditure favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the material, metal stents has the highest market share in the vascular stents market.
This report identifies the vascular stents market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the vascular stents market.
This report segments the vascular stents market on the basis of material, and regional market as follows:
The report has focused study on vascular stents market on the basis of material such as: Metal Stents, Standard Polymeric Stents, and Biodegradable Polymeric Stents
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the vascular stents market. Some of the major companies’ profiles in detail are as follows:
Goodman Co. Ltd.
InnoCore Technologies BV.
Boston Scientific Corporation
MicroPort Scientific Corp.
Reva Medical Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Vascular Stents Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Vascular Stents Market– Forces
4.1.1. Development of efficient and advance technology
4.1.2. Growing number of patients suffering from cardiovascular disease
4.2.1. Higher cost of vascular stents
4.3.1. Emerging economies
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Vascular Stents Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Vascular Stents Market, By Material
6.1. Metal Stents
6.2. Standard Polymeric Stents
6.3. Biodegradable Polymeric Stents
7. Vascular Stents Market, By Geography
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.4. Rest of the World (RoW)
7.4.2. Rest of RoW
8. Vascular Stents – Entropy
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Goodman Co. Ltd.
9.2. InnoCore Technologies BV.
9.3. Boston Scientific Corporation
9.4. MicroPort Scientific Corp.
9.5. Reva Medical Inc.
9.6. Cook Medical
9.7. Medtronic Inc.
9.8. Allvivo Vascular Inc.
9.9. Stentys SA,
9.10. Abbott Vascular
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10.3. Research Methodology
10.5. Compilation of Expert Insights